Status: current, Defined. Date: 31-Oct 2015. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1458091000168117 | carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL intestinal gel, 7 x 100 mL (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
1458101000168110 | levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL | Is a | medicinal product pack | true | Inferred relationship | Some | ||
levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL | has MPUU | levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | true | Inferred relationship | Some | 2 | |
levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL | has subpack | levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 100 mL | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel, 7 x 100 mL (trade product pack) | Is a | True | levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set